Objective: Bucillamine is a disease-modifying antirheumatic drug that's widely used in Korea and Japan, and it is reported to be a cause of proteinuria. However, the clinical course of the nephropathy associated with the use of bucillamine in rheumatoid arthritis patients has not been described in detail in Korea.
대상 및 방법 These data were assessed using a Mann-Whitney U test. Low dose of steroid was defined as taking ≤10 mg/d of prednisolone equivalent. Moderate to high dose of steroid was defined as taking over 10 mg of prednisolone equivalent 참고문헌
